Human RAGE antibody protects against AGE-mediated podocyte dysfunction
Open Access
- 17 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 27 (8), 3129-3136
- https://doi.org/10.1093/ndt/gfs005
Abstract
Residual renal function (RRF) contributes to better patient survival in peritoneal dialysis (PD). It is known that glucose degradation products (GDP) and advanced glycation end-products (AGE) resorbed from the peritoneal cavity do not only cause local peritoneal toxicity but also systemic damage resulting in a loss of RRF. We hypothesize that GDP and AGE affect the structure and function of podocytes and investigate whether these effects can be rescued by human RAGE antibody (hRAGEab) to prevent AGE/RAGE interaction and podocyte damage. Differentiated human podocytes were pre-incubated with ±hRAGEab to block the AGE/RAGE interaction and incubated afterwards either with control solution (control), PD fluid (PDF) or a GDP mixture (GDP) for 48 h. We analysed podocyte damage and rescue by hRAGEab using immunofluorescence, western blot, enzyme-linked immunosorbent assay and a functional migration assay. For quantitation, a semiquantitative score was used. When pre-incubating podocytes with hRAGEab, damage mediated by PDF and GDP was reduced. We observed lower expression of AGE in PDF and GDP as well as decreased levels of inflammation as shown by activation of nuclear factor kappa B and interleukin-6 release. The reorganization of the podocyte actin cytoskeleton was reduced in the presence of hRAGEab as well as ameliorated synaptopodin expression could be observed, both functionally associated with normal podocyte motility. Finally, podocytes underwent less apoptosis. It has been investigated that GDP-containing PDF causes a loss of RRF in PD. Our findings suggest that hRAGEab confers protection against PDF- and GDP-induced podocyte dysfunction. Blocking the AGE/RAGE interaction provides specific protective effects against PDF- and GDP-induced cytoskeletal reorganization, dynamics and stabilizes podocyte survival; this might be an implication for the preservation of RRF in PD.This publication has 26 references indexed in Scilit:
- CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survivalJCI Insight, 2011
- Benfotiamine Protects against Peritoneal and Kidney Damage in Peritoneal DialysisJournal of the American Society of Nephrology, 2011
- αV-Integrins mediate the mechanoprotective action of osteopontin in podocytesAmerican Journal of Physiology-Renal Physiology, 2011
- Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failureEuropean Journal of Clinical Investigation, 2008
- Effect of peritoneal dialysis on renal morphology and functionNephrology Dialysis Transplantation, 2006
- Damage to the Peritoneal Membrane by Glucose Degradation Products Is Mediated by the Receptor for Advanced Glycation End-ProductsJournal of the American Society of Nephrology, 2006
- WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatmentAmerican Journal of Physiology-Renal Physiology, 2005
- TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal functionNature Genetics, 2005
- Advanced Glycation End Products Induce Tubular Epithelial-Myofibroblast Transition through the RAGE-ERK1/2 MAP Kinase Signaling PathwayThe American Journal of Pathology, 2004
- Peritoneal dialysis adequacy and risk of deathKidney International, 2000